Here is a comprehensive overview of ATP7A defects, synthesized from multiple authoritative medical textbooks.
ATP7A Defect - Menkes Disease (and Allelic Variants)
Gene and Protein
ATP7A (Xq21.1) encodes a P-type ATPase copper transporter - a 1500-amino acid transmembrane protein located on the trans-Golgi membrane. Its roles are:
- Export dietary copper from enterocytes into the portal circulation
- Deliver intracellular copper to cuproenzymes within the Golgi apparatus
- Efflux of excess copper from most cells (except hepatocytes, which rely on the homologous ATP7B)
Loss-of-function mutations in ATP7A impair copper egress from intestinal epithelial cells, causing copper to accumulate in enterocytes while systemic tissues suffer profound copper deficiency. - Emery's Elements of Medical Genetics and Genomics, p. 294; Andrews' Diseases of the Skin, p. 4002
Allelic Spectrum
| Disorder | Severity | Key Features |
|---|
| Classic Menkes disease | Severe | Neurodegeneration, kinky hair, early death |
| Occipital Horn Syndrome (OHS) | Moderate | Connective tissue > neurological |
| ATP7A-related distal motor neuropathy | Mild | Adult-onset, Charcot-Marie-Tooth-like |
Classic Menkes Disease
Inheritance and Epidemiology
- X-linked recessive - affects males almost exclusively
- Prevalence: ~1 in 35,000 live male births (possibly as high as 1:8,664 by genome-based ascertainment)
- Typically presents after a normal 6-12 week honeymoon period
Pathophysiology
Because ATP7A is absent or non-functional, copper cannot be exported from intestinal enterocytes. Most cuproenzymes are therefore deprived of their cofactor:
| Enzyme | Normal Function | Effect of Deficiency |
|---|
| Cytochrome C oxidase | Mitochondrial electron transport | Neurodegeneration, energy failure |
| Lysyl oxidase | Cross-linking collagen/elastin | Connective tissue laxity, vascular fragility, kinky hair |
| Dopamine beta-hydroxylase | Norepinephrine synthesis | Autonomic dysfunction |
| Tyrosinase | Melanin synthesis | Depigmented hair |
| Superoxide dismutase | Free radical defense | Oxidative damage |
| Ceruloplasmin | Copper/iron transport | Low serum ceruloplasmin |
| Peptidylglycine alpha-amidating monooxygenase (PAM) | Neuroendocrine peptide processing | Hormonal dysregulation |
Lysyl oxidase requires copper to oxidatively deaminate lysyl residues, forming the cross-links essential for collagen and elastin integrity - this explains both the connective tissue findings and the twisted, brittle hair. - Harper's Illustrated Biochemistry 32e, p. 2888
Clinical Features
Prodrome (0-6 weeks): Normal birth and early development.
Early presentation (2-3 months):
- Feeding difficulties, vomiting, poor weight gain
- Seizures (often infantile spasms / hypsarrhythmia on EEG)
- Hypothermia
Characteristic features:
- Kinky/steely hair (pili torti + trichorrhexis nodosa + monilethrix) - ivory-white, wiry, sparse, twisted, brittle; resembles steel wool or copper-deficient sheep's wool
- Facies: pudgy face, exaggerated "Cupid's bow" upper lip
- Skin: pale, lax
Neurological:
- Progressive hypotonia
- Psychomotor regression / severe developmental delay
- Uncontrollable seizures progressing to status epilepticus
- Neuropathology: neovascularization of cerebral arteries, cystic medial degeneration, cerebellar hypoplasia, focal cortical dysplasias, profound Purkinje cell loss
Connective tissue:
- Osteoporosis, joint laxity
- Vascular anomalies (arterial tortuosity)
Ophthalmology: Ocular abnormalities
Prognosis: Death usually by 2-3 years from recurrent respiratory infections and neurological deterioration. - Bradley and Daroff's Neurology in Clinical Practice; Andrews' Diseases of the Skin
Occipital Horn Syndrome (OHS)
A milder allelic variant - hypomorphic ATP7A mutations preserve some protein function. Predominantly a connective tissue disorder presenting in early-to-middle childhood:
- Occipital horns (wedge-shaped bony exostoses at skull base - sites of trapezius/sternomastoid attachment)
- Skin and joint laxity (cutis laxa phenotype)
- Bladder diverticula, inguinal hernias
- Minimal neurological involvement
- Patients survive into adulthood
ATP7A mediates copper transport into the Golgi for lysyl oxidase activation - reduced activity preferentially impacts connective tissue cross-linking. - Fitzpatrick's Dermatology, p. 3510
ATP7A-Related Distal Motor Neuropathy
- Adult-onset, progressive distal motor neuropathy resembling Charcot-Marie-Tooth disease
- Pes cavus, distal muscle wasting
- No copper/ceruloplasmin abnormalities
- Caused by missense mutations preserving partial copper transport
Genetics and Mutation Spectrum
- Gene locus: Xq21.1 (X-linked, so affected females are very rare - reported with X-autosome translocations disrupting the gene)
- ~15-20% large deletions (usually classic severe phenotype)
- Point mutations: 23% splice-site, 21% nonsense, 17% missense, 39% small deletions/insertions
- Variable expressivity even with identical mutations within a family
Diagnosis
| Test | Finding |
|---|
| Serum copper | Very low |
| Serum ceruloplasmin | Very low |
| Catechol ratio (DOPA/DHPG) | High DOPA, dopamine, DOPAC; low DHPG - reflects dopamine beta-hydroxylase deficiency |
| Hair microscopy | Pili torti, trichorrhexis nodosa, monilethrix |
| Skin fibroblast copper egress studies | Abnormal |
| Molecular: ATP7A gene sequencing | Confirms mutation |
The catechol metabolite ratio (reflecting impaired dopamine-beta-hydroxylase) is a sensitive early biomarker for neonatal diagnosis. - Andrews' Diseases of the Skin, p. 4002
Treatment
- Copper-histidine (subcutaneous or IV): Partially bypasses the intestinal block. Restores serum copper and ceruloplasmin. Best results when started before neurological deterioration (neonatal period). - Bradley and Daroff's Neurology
- Pamidronate: Improves bone mineral density
- Gene therapy / antisense oligonucleotides: Experimental (promising results in zebrafish models and early human trials with viral-mediated ATP7A gene therapy)
- L-threo-DOPS (L-threo-dihydroxyphenylserine): Corrects neurochemical abnormalities in mouse models
Comparison with Wilson Disease (ATP7B)
| Feature | Menkes (ATP7A) | Wilson (ATP7B) |
|---|
| Gene | ATP7A (Xq21.1) | ATP7B (13q14) |
| Inheritance | X-linked recessive | Autosomal recessive |
| Primary organ | Intestine (efflux) | Liver (biliary excretion) |
| Copper result | Systemic deficiency | Systemic accumulation |
| Onset | Infancy | Childhood/young adult |
| Serum copper/ceruloplasmin | Low | Low (despite accumulation) |
| Treatment | Copper supplementation | Chelation (D-penicillamine, trientine) |
Sources: - Emery's Elements of Medical Genetics and Genomics, p. 294 | - Harper's Illustrated Biochemistry 32e, p. 2888 | - Bradley and Daroff's Neurology in Clinical Practice | - Andrews' Diseases of the Skin, p. 4002-4004 | - Fitzpatrick's Dermatology, p. 3510 | - Dermatology 2-Volume Set 5e | -
GeneReviews: ATP7A-Related Copper Transport Disorders